EM 652

Known as: EM-652 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
OBJECTIVE EM-652 is a pure antiestrogen in human breast and uterine cancer cells that also reduces bone loss and plasma lipid… Expand
Is this relevant?
2003
2003
Estrogen receptor (ER)alpha and -beta interact with a variety of coactivator proteins, most notably members of the steroid… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2003
2003
OBJECTIVE Selective estrogen receptor modulators (SERMs) represent a class of compounds that act as either estrogen receptor… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2002
2002
EM-652 exerts pure antiestrogenic activity in the mammary gland and endometrium, while tamoxifen, the antiestrogen most widely… Expand
Is this relevant?
Review
2001
Review
2001
A new understanding of the endocrinology of menopause is that women, at menopause, are not only lacking estrogens resulting from… Expand
Is this relevant?
Review
2001
Review
2001
In order to minimize the risks of endometrial cancer and the development of resistance to antiestrogen therapy, we have… Expand
Is this relevant?
2001
2001
Coregulators for nuclear receptors (NR) are factors that either enhance or repress their transcriptional activity. Both… Expand
Is this relevant?
Review
1999
Review
1999
Breast cancer is the most frequent cancer in women while it is the second cause of cancer death. Estrogens are well recognized to… Expand
Is this relevant?
1998
1998
Estrogens act as potent mitogens in a large number of breast cancers, and the use of estrogen receptor (ER) antagonists is… Expand
Is this relevant?
1998
1998
It has recently been suggested that mutation of a conserved tyrosine to asparagine within the ligand-binding domain of the… Expand
Is this relevant?